MedPath

A Prospective Randomised Controlled Trial of Iron Supplementation in Patients Scheduled for Colorectal Cancer Surgery

Completed
Conditions
Cancer: Colorectal
Cancer
Malignant neoplasm of colon, malignant neoplasm of rectum
Registration Number
ISRCTN61221573
Lead Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All patients seen in clinic with a diagnosis of colorectal cancer and fit for surgery will be eligible.

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine whether giving iron supplements to patients at the time of diagnosis of colorectal cancer increases, or prevents the decrease, in their haemoglobin levels, and reduces allogeneic blood exposure.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath